Patent ID: 11866438
Assignee: PIMERA, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 1:
2. The method of claim 1, or a pharmaceutically acceptable salt, hydrate, or tautomer thereof, wherein:
L is a C1-C10 alkylene or C1-C10 heteroalkylene linker, each of which is optionally substituted with one or more substituents selected from the group consisting of halogen, oxo (═O), and C1-C6 alkyl;
A is heterocycloalkyl, heteroaryl, or NR4R5;
X is NR6, or O;
R6 is H, optionally substituted C1-C8 alkyl, C2-C8 heteroalkyl, C2-C8 alkenyl, C2-C8 heteroalkenyl, C2-C8 alkynyl, C2-C8 heteroalkynyl, C1-C8 acyl, C2-C8 heteroacyl, C6-C10 aryl, C5-C10 heteroaryl, C7-C12 arylalkyl, or C6-C12 heteroarylalkyl group;
or R6 can be linked to R4 or R5 to form a 3-8 membered ring;
or A-L-X— is:, (U)n and (U)m are each independently H, halogen, CF3, CN, OR7, or NR8R9;
wherein each R7, R8 and R9 is independently selected from H, and C1-C6 alkyl.